Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Octapharma Plasma is the U.S.-based plasma collection subsidiary of Octapharma AG, one of the world's largest human protein product manufacturers. The company operates more than 150 state-of-the-art plasma donation centers across the United States, ensuring a stable supply of high-quality raw material for life-saving therapies. These plasma-derived medicines are used to treat patients with rare, chronic, and genetic conditions in the fields of hematology, immunology, and critical care. Octapharma Plasma is committed to donor safety and clinical excellence, adhering to strict FDA and international regulatory standards. Through its extensive network, the company supports the production of essential treatments such as coagulation factors and immunoglobulins. Its operations are integral to the global mission of providing safe and effective human protein therapies to improve patient health outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Octapharma Plasma.